vanadates has been researched along with Diabetes Mellitus, Type 2 in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.86) | 18.7374 |
| 1990's | 12 (34.29) | 18.2507 |
| 2000's | 15 (42.86) | 29.6817 |
| 2010's | 7 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharya, S; Chatterjee, SK; Chattopadhyay, D; Chaudhuri, MK; Das, S; Majumdar, SS; Mukherjee, S; Mukhopadhyay, S; Sarkar, S; Talukdar, D | 1 |
| Du, W; Gong, G; Huang, X; Xu, J | 1 |
| Guo, Y; Jie, X; Liu, Y; Wang, J; Xue, C; Zhang, X | 1 |
| Guo, Y; Liu, Y; Wang, J; Xu, J; Xue, C; Xue, Y | 1 |
| LeBel, C; Lichter, J; McNeill, JH; Orvig, C; Scaife, MC; Thompson, KH | 1 |
| Gao, Z; Wang, K; Yang, X; Yu, S; Zhang, C | 1 |
| Chen, JX; Liao, DF; Tuo, Q; Zeng, H | 1 |
| Castro, MM; López-Larrubia, P; Metelo, AM; Pérez-Carro, R | 1 |
| Abella, A; Camps, M; Carpéné, C; Claret, M; Fernández-Alvarez, J; Gomis, R; Gumà, A; Marti, L; Palacín, M; Testar, X; Viguerie, N; Zorzano, A | 1 |
| Huisamen, B | 1 |
| Clark, TA; Edel, AL; Heyliger, CE; Pierce, GN | 1 |
| Davis, MG; Downs, TR; Gerwe, GS; Kasibhatla, B; Lange, JS; Peters, KG; Winter, CL | 1 |
| Chen, J; Ostenson, CG | 1 |
| Truett, GE | 1 |
| Kamata, K; Kobayashi, T; Matsumoto, T | 1 |
| Folli, F; Goldfine, AB; Kahn, CR; Patti, ME; Simonson, DC | 1 |
| Shechter, Y; Shisheva, A | 1 |
| Khandelwal, RL; King, MJ; Pugazhenthi, S; Sharma, RK | 1 |
| Angel, JF; Khandelwal, RL; Pugazhenthi, S | 1 |
| Eriksson, JW; Jansson, PA; Posner, BI; Smith, U; Yu, ZW | 1 |
| Baba, S; Okada, Y; Shii, K; Yoshida, M | 1 |
| DeFronzo, RA; Mandarino, L; Matsuda, M | 1 |
| Crans, DC; Goldfine, AB; Khan, HR; Kostyniak, PJ; McNeill, JH; Willsky, GR; Yang, LQ | 1 |
| Goto, T; Kawamura, I; Kimura, C; Sakurai, H; Seki, J; Takeshita, S; Tamura, A; Yamamoto, T; Yasuno, T | 1 |
| Ding, W; Hasegawa, T; Hosaka, H; Peng, D; Seko, Y; Takahashi, K | 1 |
| Anilkumar, KL; Marita, AR | 1 |
| Bhanot, S; McNeill, JH; Mohammad, A | 1 |
| Bhanot, S; Marzban, L; McNeill, JH | 1 |
| Goyal, RK; Mehta, AA; Shinde, UA | 1 |
| Brichard, SM; Henquin, JC | 1 |
| Klein, DJ; Robertson, RP | 1 |
| Bailbé, D; Blondel, O; Portha, B; Serradas, P | 1 |
| Blondel, O; Chevalier, B; Portha, B; Simon, J | 1 |
| Ciaraldi, TP; Freidenberg, GR; Molina, JM; Olefsky, JM; Thies, RS | 1 |
| Lauglin, MR; Rossetti, L | 1 |
5 review(s) available for vanadates and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Vanadium treatment of type 2 diabetes: a view to the future.
Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Organometallic Compounds; Pyrones; Vanadates | 2009 |
Protein kinase B in the diabetic heart.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Enzyme Activation; Glucose; Insulin; Myocardium; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Zucker; Vanadates | 2003 |
Vanadium salts and the future treatment of diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Vanadates; Vanadium | 1993 |
[Role of vanadium in the treatment of diabetes mellitus. Experimental data and clinical applications].
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Rats; Vanadates; Vanadium | 1992 |
Treatment of diabetes mellitus.
Topics: Animals; Antihypertensive Agents; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Insulin; Islets of Langerhans Transplantation; Pancreas Transplantation; Rats; Rats, Inbred SHR; Risk Factors; Vanadates | 1992 |
3 trial(s) available for vanadates and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies.
Topics: Adult; Aged; Calcium-Calmodulin-Dependent Protein Kinases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Islets of Langerhans; Male; Middle Aged; Mitogen-Activated Protein Kinase 1; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Ribosomal Protein S6 Kinases; Vanadates | 1995 |
Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV).
Topics: Animals; Apoproteins; Biological Availability; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Electron Spin Resonance Spectroscopy; Fasting; Humans; Hypoglycemic Agents; Immunoglobulin G; Male; Pyrones; Rats; Rats, Wistar; Serum Albumin; Streptozocin; Transferrin; Treatment Outcome; Vanadates; Vanadium; Vanadium Compounds | 2001 |
Insulin-receptor autophosphorylation and endogenous substrate phosphorylation in human adipocytes from control, obese, and NIDDM subjects.
Topics: Adipose Tissue; Adult; Animals; Biological Transport; Cell Fractionation; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Glucose; Humans; Hydrogen Peroxide; Immunoblotting; Insulin; Insulin Resistance; Membrane Proteins; Obesity; Phosphorylation; Protein-Tyrosine Kinases; Rats; Rats, Inbred Strains; Receptor, Insulin; Temperature; Tyrosine; Vanadates; Wheat Germ Agglutinins | 1990 |
27 other study(ies) available for vanadates and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Attenuation of macrophage accumulation and polarisation in obese diabetic mice by a small molecule significantly improved insulin sensitivity.
Topics: Animals; Cell Polarity; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Inflammation; Insulin Resistance; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Obese; Obesity; RAW 264.7 Cells; Vanadates | 2018 |
Schiff base oxovanadium complexes resist the assembly behavior of human islet amyloid polypeptide.
Topics: Antidiarrheals; Diabetes Mellitus, Type 2; Humans; Islet Amyloid Polypeptide; Protein Aggregates; Schiff Bases; Vanadates | 2018 |
Green Synthesis of Oxovanadium(IV)/chitosan Nanocomposites and Its Ameliorative Effect on Hyperglycemia, Insulin Resistance, and Oxidative Stress.
Topics: Animals; Chitosan; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Stability; Glucose Tolerance Test; Green Chemistry Technology; Hyperglycemia; Insulin Resistance; Liver; Male; Mice, Inbred C57BL; Nanocomposites; Oxidative Stress; Vanadates | 2016 |
Ameliorative effect of vanadyl(IV)-ascorbate complex on high-fat high-sucrose diet-induced hyperglycemia, insulin resistance, and oxidative stress in mice.
Topics: Adiponectin; Adipose Tissue; Animals; Ascorbic Acid; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Diet, High-Fat; Feeding Behavior; Glucose Tolerance Test; Homeostasis; Hyperglycemia; Insulin; Insulin Resistance; Leptin; Liver; Male; Malondialdehyde; Mice, Inbred C57BL; Nitric Oxide; Organ Size; Oxidative Stress; Resistin; Sucrose; Tumor Necrosis Factor-alpha; Vanadates | 2015 |
Vanadyl bisacetylacetonate protects β cells from palmitate-induced cell death through the unfolded protein response pathway.
Topics: Animals; Apoptosis; Calcium; Cell Death; Cell Line; Cytoprotection; Diabetes Mellitus, Type 2; Endoplasmic Reticulum; Fatty Acids, Nonesterified; Hydroxybutyrates; Insulin; Insulin-Secreting Cells; Mice; Mice, Inbred NOD; Mice, Transgenic; Palmitates; Pentanones; Reactive Oxygen Species; Signal Transduction; Unfolded Protein Response; Vanadates | 2011 |
Inhibition of protein tyrosine phosphatase improves angiogenesis via enhancing Ang-1/Tie-2 signaling in diabetes.
Topics: Angiopoietin-1; Animals; Apoptosis; Caspase 3; Cell Line; Cells, Cultured; Diabetes Mellitus, Type 2; Endothelial Cells; Heart; Mice; Myocardium; Neovascularization, Physiologic; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Pyrones; Receptor, TIE-2; Signal Transduction; Vanadates | 2012 |
VO(dmpp)2 normalizes pre-diabetic parameters as assessed by in vivo magnetic resonance imaging and spectroscopy.
Topics: Animals; Body Weight; Diabetes Mellitus, Type 2; Glucose Intolerance; Lipid Metabolism; Liver; Magnetic Resonance Imaging; Obesity; Organometallic Compounds; Radiography; Rats; Rats, Zucker; Subcutaneous Fat; Triglycerides; Vanadates | 2012 |
Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 activity exerts an antidiabetic action in Goto-Kakizaki rats.
Topics: Adipocytes; Amine Oxidase (Copper-Containing); Animals; Benzylamines; Biological Transport; Blood Glucose; Cell Adhesion Molecules; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glucose; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Muscle, Skeletal; Peroxides; Phosphorylation; Phosphotyrosine; Protein Tyrosine Phosphatases; Rats; Rats, Wistar; Recombinant Proteins; Vanadates | 2003 |
Effective control of glycemic status and toxicity in Zucker diabetic fatty rats with an orally administered vanadate compound.
Topics: Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Diarrhea; Glycemic Index; Male; Rats; Rats, Zucker; Vanadates | 2004 |
A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato)oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glucose Tolerance Test; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Obesity; Pancreas; Protein Tyrosine Phosphatases; Pyrones; Rats; Rats, Zucker; Time Factors; Vanadates | 2005 |
Inhibition of protein-tyrosine phosphatases stimulates insulin secretion in pancreatic islets of diabetic Goto-Kakizaki rats.
Topics: Androstadienes; Animals; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glucose; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Protein Tyrosine Phosphatases; Rats; Rats, Mutant Strains; Rats, Wistar; Vanadates; Wortmannin | 2005 |
Prevention of diabetes by inhibition of tyrosine phosphatases.
Topics: Adult; Animals; Body Weight; Child; Diabetes Mellitus, Type 2; Eating; Humans; Insulin; Protein Tyrosine Phosphatases; Pyrones; Receptor, Insulin; Signal Transduction; Vanadates | 2006 |
Mechanisms underlying lysophosphatidylcholine-induced potentiation of vascular contractions in the Otsuka Long-Evans Tokushima Fatty (OLETF) rat aorta.
Topics: Animals; Aorta, Thoracic; Brimonidine Tartrate; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Lysophosphatidylcholines; Male; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Potassium; Protein Kinase Inhibitors; Protein Tyrosine Phosphatases; Quinoxalines; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Receptors, G-Protein-Coupled; RNA, Messenger; Up-Regulation; Vanadates; Vasoconstriction; Vasoconstrictor Agents | 2006 |
Membrane-associated N-myristoyltransferase activity is reduced in obese (fa/fa) Zucker rat liver.
Topics: Acyltransferases; Animals; Blood Glucose; Body Weight; Brain; Cell Membrane; Diabetes Mellitus; Diabetes Mellitus, Type 2; Insulin; Liver; Male; Obesity; Rats; Rats, Sprague-Dawley; Rats, Zucker; Vanadates | 1993 |
Effects of vanadate administration on the high sucrose diet-induced aberrations in normal rats.
Topics: Animals; Apolipoproteins B; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Insulin; Insulin Resistance; Liver; Male; Rats; Rats, Sprague-Dawley; Sucrose; Triglycerides; Vanadates | 1993 |
Peroxovanadate and insulin action in adipocytes from NIDDM patients. Evidence against a primary defect in tyrosine phosphorylation.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adipocytes; Adrenergic beta-Agonists; Adult; Animals; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Humans; Hypoglycemic Agents; Insulin; Isoproterenol; Lipolysis; Male; Mice; Middle Aged; Phosphorylation; Receptor, Insulin; Tyrosine; Vanadates | 1997 |
Development of vanadate sensitive human erythrocytes insulin receptor tyrosine phosphatase assay.
Topics: Animals; Antibodies, Monoclonal; CHO Cells; Cricetinae; Diabetes Mellitus, Type 2; Erythrocytes; Europium; Fluorometry; Humans; Insulin; Middle Aged; Phosphorylation; Protein Tyrosine Phosphatases; Receptor, Insulin; Vanadates | 1998 |
Synergistic interaction of magnesium and vanadate on glucose metabolism in diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Synergism; Glucose Clamp Technique; Glycogen; Glycolysis; Hypoglycemic Agents; Magnesium Compounds; Male; Rats; Rats, Sprague-Dawley; Vanadates | 1999 |
Amelioration of insulin resistance in diabetic ob/ob mice by a new type of orally active insulin-mimetic vanadyl complex: bis(1-oxy-2-pyridinethiolato)oxovanadium(IV) with VO(S(2)O(2)) coordination mode.
Topics: 3T3 Cells; Adipose Tissue; Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Kinetics; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Organometallic Compounds; Phosphoproteins; Phosphorylation; Triglycerides; Tumor Necrosis Factor-alpha; Vanadates | 2001 |
Effect of long-term treatment with vanadate in drinking water on KK mice with genetic non-insulin-dependent diabetes mellitus.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Drinking; Eating; Glucose Tolerance Test; Glycated Hemoglobin; Male; Mice; Mice, Mutant Strains; Organ Size; Vanadates | 2001 |
Effect of vanadate on glycogen synthesis in dexamethasone-treated 3T3 adipocytes: evidence for a novel insulin sensitizing action.
Topics: 3T3 Cells; Adipocytes; Animals; Carbon Radioisotopes; Cell Differentiation; Dexamethasone; Diabetes Mellitus, Type 2; Glucose; Glycogen; Humans; Insulin; Insulin Resistance; Kinetics; Lithium; Mice; Vanadates | 2001 |
In vivo effects of vanadium in diabetic rats are independent of changes in PI-3 kinase activity in skeletal muscle.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Insulin; Male; Muscle, Skeletal; Phosphatidylinositol 3-Kinases; Pyrones; Rats; Rats, Wistar; Rats, Zucker; Signal Transduction; Vanadates | 2001 |
In vivo effects of insulin and bis(maltolato)oxovanadium (IV) on PKB activity in the skeletal muscle and liver of diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose Tolerance Test; Insulin; Liver; Male; Muscle, Skeletal; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyrones; Random Allocation; Rats; Rats, Wistar; Rats, Zucker; Tissue Extracts; Vanadates | 2001 |
Effect of chronic treatment with Bis(maltolato)oxovanadium (IV) in rat model of non-insulin-dependent-diabetes.
Topics: Animals; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose Tolerance Test; Hypercholesterolemia; Hypoglycemic Agents; Insulin; Male; Pyrones; Rats; Rats, Wistar; Vanadates | 2001 |
Abnormal B-cell function in rats with non-insulin-dependent diabetes induced by neonatal streptozotocin: effect of in vivo insulin, phlorizin, or vanadate treatments.
Topics: Animals; Arginine; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; In Vitro Techniques; Insulin; Insulin Secretion; Male; Pancreas; Phlorhizin; Rats; Rats, Inbred Strains; Vanadates | 1991 |
Impaired insulin action but normal insulin receptor activity in diabetic rat liver: effect of vanadate.
Topics: Animals; Blood Glucose; Cell Membrane; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Insulin; Insulin Resistance; Liver; Liver Glycogen; Phosphoenolpyruvate Carboxykinase (GTP); Phosphorylation; Rats; Rats, Inbred Strains; Receptor, Insulin; Reference Values; Vanadates | 1990 |
Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle.
Topics: Animals; Chronic Disease; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose Clamp Technique; Glycogen; Glycogen Synthase; Hyperglycemia; Insulin; Liver; Male; Muscles; Phlorhizin; Rats; Rats, Inbred Strains; Vanadates | 1989 |